• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症患者身体成分变化的评估和管理。

Evaluation and management of body composition changes in cancer patients.

机构信息

Department of General Surgery/Shanghai Clinical Nutrition Research Center, Zhongshan Hospital, Fudan University, Shanghai, China.

School of Medicine and Surgery, University of Milano-Bicocca, and HBP Surgery Unit, and Foundation IRCCS San Gerardo, Monza, Italy.

出版信息

Nutrition. 2023 Oct;114:112132. doi: 10.1016/j.nut.2023.112132. Epub 2023 Jun 14.

DOI:10.1016/j.nut.2023.112132
PMID:37441827
Abstract

Wasting in cancer patients has long been recognized as a condition that adversely affects cancer patients' quality of life, treatment tolerance, and oncological outcomes. Historically, this condition was mainly evaluated by changes in body weight. However, this approach is not quite accurate because body weight is the overall change of all body compartments. Conditions such as edema and ascites can mask the severity of muscle and adipose tissue depletion. Changes in body composition assessment in cancer patients have historically been underappreciated because of the limited availability of measurement tools. As more evidence highlighting the importance of body composition has emerged, it is imperative to apply a more precise evaluation of nutritional status and a more targeted approach to provide nutritional support for cancer patients. In this review, we will discuss the modalities for evaluating body composition and how to manage body composition changes in cancer patients.

摘要

癌症患者的消瘦问题一直以来都被认为是一种会对患者的生活质量、治疗耐受性和肿瘤预后产生不良影响的情况。从历史上看,这种情况主要通过体重变化来评估。然而,这种方法并不十分准确,因为体重是所有身体部位的总体变化。水肿和腹水等情况可能会掩盖肌肉和脂肪组织消耗的严重程度。由于测量工具的缺乏,癌症患者的身体成分评估在历史上一直被低估。随着越来越多的证据强调身体成分的重要性,有必要更精确地评估营养状况,并采取更有针对性的方法为癌症患者提供营养支持。在这篇综述中,我们将讨论评估身体成分的方法以及如何管理癌症患者的身体成分变化。

相似文献

1
Evaluation and management of body composition changes in cancer patients.癌症患者身体成分变化的评估和管理。
Nutrition. 2023 Oct;114:112132. doi: 10.1016/j.nut.2023.112132. Epub 2023 Jun 14.
2
Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival.减肥和肌肉减少症对化疗反应、生活质量和生存的影响。
Nutrition. 2019 Nov-Dec;67-68:110539. doi: 10.1016/j.nut.2019.06.020. Epub 2019 Jun 28.
3
Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.癌症恶病质的研究进展:受影响器官、介质和药物干预的交叉点。
Biochim Biophys Acta Rev Cancer. 2020 Apr;1873(2):188359. doi: 10.1016/j.bbcan.2020.188359. Epub 2020 Mar 25.
4
Eicosapentaenoic acid in cancer improves body composition and modulates metabolism.癌症中的二十碳五烯酸可改善身体成分并调节新陈代谢。
Nutrition. 2015 Apr;31(4):549-55. doi: 10.1016/j.nut.2014.12.002. Epub 2014 Dec 12.
5
Contribution of skeletal muscle to cancer immunotherapy: A focus on muscle function, inflammation, and microbiota.骨骼肌在癌症免疫治疗中的作用:聚焦肌肉功能、炎症和微生物组。
Nutrition. 2023 Jan;105:111829. doi: 10.1016/j.nut.2022.111829. Epub 2022 Aug 21.
6
Sarcopenia and cachexia in chronic diseases: from mechanisms to treatment.慢性疾病中的肌肉减少症和恶病质:从机制到治疗。
Pol Arch Intern Med. 2021 Dec 22;131(12). doi: 10.20452/pamw.16135. Epub 2021 Nov 15.
7
A window beneath the skin: how computed tomography assessment of body composition can assist in the identification of hidden wasting conditions in oncology that profoundly impact outcomes.皮肤下的窗口:体成分计算机断层评估如何帮助识别肿瘤学中隐藏的消耗状况,这些状况对结果有深远影响。
Proc Nutr Soc. 2018 May;77(2):135-151. doi: 10.1017/S0029665118000046.
8
Cachexia and sarcopenia: mechanisms and potential targets for intervention.恶病质与肌肉减少症:发病机制及潜在干预靶点
Curr Opin Pharmacol. 2015 Jun;22:100-6. doi: 10.1016/j.coph.2015.04.003. Epub 2015 May 14.
9
Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact.肥胖时代的肌肉减少症和恶病质:临床和营养影响。
Proc Nutr Soc. 2016 May;75(2):188-98. doi: 10.1017/S0029665115004279. Epub 2016 Jan 8.
10
Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?癌症恶病质治疗的核心原则:晚期癌症患者是否具有可利用的合成代谢潜力?
Am J Clin Nutr. 2013 Oct;98(4):1012-9. doi: 10.3945/ajcn.113.060228. Epub 2013 Aug 21.

引用本文的文献

1
Visceral Adipose Predicts Prognosis and Toxicities in Locally Advanced Bladder Cancer Patients Treated With Adjuvant Gemcitabine Plus Cisplatin Chemotherapy.内脏脂肪可预测接受吉西他滨联合顺铂辅助化疗的局部晚期膀胱癌患者的预后和毒性。
Cancer Med. 2025 Apr;14(7):e70742. doi: 10.1002/cam4.70742.
2
Prognostic Impact of Sarcopenia and Surgical Timing in Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoradiotherapy: TIMES Study.肌少症及手术时机对接受新辅助放化疗的局部晚期食管鳞状细胞癌的预后影响:TIMES研究
Ann Surg Oncol. 2025 Jun;32(6):4140-4150. doi: 10.1245/s10434-025-16976-9. Epub 2025 Feb 9.
3
Multiparameter body composition analysis on chest CT predicts clinical outcomes in resectable non-small cell lung cancer.
胸部CT的多参数身体成分分析可预测可切除非小细胞肺癌的临床结局。
Insights Imaging. 2025 Feb 6;16(1):32. doi: 10.1186/s13244-025-01910-0.
4
Racial-Ethnic Disparities of Obesity Require Community Context-Specific Biomedical Research for Native Hawaiians and Other Pacific Islanders.肥胖的种族差异需要针对夏威夷原住民和其他太平洋岛民开展特定社区背景的生物医学研究。
Nutrients. 2024 Dec 11;16(24):4268. doi: 10.3390/nu16244268.
5
Image-Based Assessment of Obesity and Metabolic Pathway Alterations in Non-small Cell Lung Cancer.基于图像的非小细胞肺癌肥胖与代谢途径改变评估
Ann Surg Oncol. 2025 Mar;32(3):1403-1405. doi: 10.1245/s10434-024-16617-7. Epub 2024 Nov 29.
6
Cancer-induced systemic pre-conditioning of distant organs: building a niche for metastatic cells.癌症诱导的远处器官系统预适应:为转移细胞构建生态位。
Nat Rev Cancer. 2024 Dec;24(12):829-849. doi: 10.1038/s41568-024-00752-0. Epub 2024 Oct 10.
7
Bioelectrical impedance analysis-derived phase angle (PhA) in lung cancer patients: a systematic review.生物电阻抗分析衍生的相位角(PhA)在肺癌患者中的应用:系统评价。
BMC Cancer. 2024 May 20;24(1):608. doi: 10.1186/s12885-024-12378-4.
8
Quantitative and Qualitative Radiological Assessment of Sarcopenia and Cachexia in Cancer Patients: A Systematic Review.癌症患者肌肉减少症和恶病质的定量与定性放射学评估:一项系统综述
J Pers Med. 2024 Feb 24;14(3):243. doi: 10.3390/jpm14030243.
9
Impact of Altered Body Composition on Clinical and Oncological Outcomes in Intrahepatic Cholangiocarcinoma.身体成分改变对肝内胆管癌临床和肿瘤学结局的影响
J Clin Med. 2023 Dec 18;12(24):7747. doi: 10.3390/jcm12247747.